fig2
![The quest for reliable prediction of chemotherapy-induced delayed nausea among breast cancer patients](https://image.oaes.cc/914abdad-bb6b-449c-8da5-ae361e12f42e/3116.fig.2.jpg)
Figure 2. Classification and regression trees evaluation of glutathione recycling capacity (GRC) as predictive factor for patients treated with taxane-based (A) or anthractcline-based (B) chemotherapy. For patients treated with taxane-based therapies, the GRC assay provides a better risk stratification than age while it does not aid in identifying patients at risk among those treated with anthracycline-based therapies